Thuy P. Nguyen, Quyet Do, Lan T. Phan, Duc V. Dinh, Hiep Khong, Luong V. Hoang, . . . Si M. Do. (2022). Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial. Elsevier.
Chicago Style (17th ed.) CitationThuy P. Nguyen, et al. Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine: Interim Results of a Double-blind, Randomised Controlled Phase 1 and 2 Trial. Elsevier, 2022.
MLA (9th ed.) CitationThuy P. Nguyen, et al. Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine: Interim Results of a Double-blind, Randomised Controlled Phase 1 and 2 Trial. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.